Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (131-140 of 218) with videos related to

Pageof 22
Sort By:
Breast Cancer Research and Treatment|March 17, 2006
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspectiveArti Hurria, Shari Goldfarb, Carol Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2026
Benralizumab relieves Eosinophil-Related Cutaneous Adverse Events from Cancer Therapy: A Nonrandomized Phase 2 TrialMario E Lacouture, Alexander Pan, Tara Maier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2022
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical OpinionDebyani Chakravarty, Amber Johnson, Jeffrey Sklar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancersKenneth Offit, Shlomit Gilad, Shoshana Paglin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancerChau Dang, Monica Fornier, Steven Sugarman, et al.
EMBO Molecular Medicine|July 2, 2024
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancerYifan Tai, Angela Chow, Seoyoung Han, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
A comparison of bilateral breast cancers in BRCA carriersJeffrey N Weitzel, Mark Robson, Barbara Pasini, et al.
JCO Precision Oncology|September 11, 2020
Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic TargetsMaria I Carlo, Nabeela Khan, Ahmet Zehir, et al.
Clinical Breast Cancer|February 12, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancerKomal Jhaveri, Sarat Chandarlapaty, Diana Lake, et al.
NPJ Breast Cancer|October 12, 2021
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombinationJeremy Setton, Pier Selenica, Semanti Mukherjee, et al.
Pageof 22

Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
Breast Cancer Research and Treatment|March 17, 2006
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspectiveArti Hurria, Shari Goldfarb, Carol Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2026
Benralizumab relieves Eosinophil-Related Cutaneous Adverse Events from Cancer Therapy: A Nonrandomized Phase 2 TrialMario E Lacouture, Alexander Pan, Tara Maier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2022
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical OpinionDebyani Chakravarty, Amber Johnson, Jeffrey Sklar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancersKenneth Offit, Shlomit Gilad, Shoshana Paglin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancerChau Dang, Monica Fornier, Steven Sugarman, et al.
EMBO Molecular Medicine|July 2, 2024
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancerYifan Tai, Angela Chow, Seoyoung Han, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
A comparison of bilateral breast cancers in BRCA carriersJeffrey N Weitzel, Mark Robson, Barbara Pasini, et al.
JCO Precision Oncology|September 11, 2020
Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic TargetsMaria I Carlo, Nabeela Khan, Ahmet Zehir, et al.
Clinical Breast Cancer|February 12, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancerKomal Jhaveri, Sarat Chandarlapaty, Diana Lake, et al.
NPJ Breast Cancer|October 12, 2021
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombinationJeremy Setton, Pier Selenica, Semanti Mukherjee, et al.
Pageof 22